Overview A Drug-drug Interaction Study of DP-R213 Status: Completed Trial end date: 2016-03-01 Target enrollment: Participant gender: Summary The purpose of this study is to learn about the effect of raloxifene on how the body absorbs and processes cholecalciferol and how cholecalciferol affects raloxifene when they are taken together. Phase: Phase 1 Details Lead Sponsor: Alvogen KoreaTreatments: CholecalciferolRaloxifene Hydrochloride